DekaBank Deutsche Girozentrale Has $22.05 Million Holdings in AMETEK, Inc. (NYSE:AME)
DekaBank Deutsche Girozentrale cut its holdings in AMETEK, Inc. (NYSE:AME) by 7.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 186,020 shares of the technology company’s stock after selling 15,576 shares during the quarter. DekaBank Deutsche Girozentrale owned approximately 0.08% of AMETEK worth $22,046,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in AME. Regent Peak Wealth Advisors LLC acquired a new stake in AMETEK in the fourth quarter valued at about $26,000. International Assets Investment Management LLC acquired a new stake in shares of AMETEK during the fourth quarter valued at about $27,000. Fieldpoint Private Securities LLC acquired a new stake in shares of AMETEK during the fourth quarter valued at about $30,000. CX Institutional boosted its stake in shares of AMETEK by 46.6% during the fourth quarter. CX Institutional now owns 302 shares of the technology company’s stock valued at $37,000 after purchasing an additional 96 shares in the last quarter. Finally, Vantage Consulting Group Inc acquired a new stake in shares of AMETEK during the fourth quarter valued at about $40,000. 85.66% of the stock is currently owned by institutional investors and hedge funds.
A number of brokerages have recently commented on AME. KeyCorp lifted their price target on AMETEK from $131.00 to $140.00 and gave the company an “overweight” rating in a research note on Thursday, April 1st. DA Davidson reissued a “buy” rating on shares of AMETEK in a research note on Tuesday, February 9th. Morgan Stanley lifted their price objective on AMETEK from $131.00 to $133.00 and gave the stock an “overweight” rating in a research note on Friday, February 5th. Finally, Rosenblatt Securities lifted their price objective on AMETEK from $140.00 to $142.00 and gave the stock a “buy” rating in a research note on Tuesday, March 30th. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. AMETEK presently has an average rating of “Buy” and an average price target of $116.13.
AMETEK stock opened at $129.55 on Thursday. The firm has a market cap of $29.90 billion, a P/E ratio of 34.27, a P/E/G ratio of 3.73 and a beta of 1.36. The stock’s 50 day moving average is $122.98 and its 200 day moving average is $115.98. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.88 and a quick ratio of 1.47. AMETEK, Inc. has a one year low of $73.11 and a one year high of $131.79.
AMETEK (NYSE:AME) last issued its earnings results on Wednesday, February 3rd. The technology company reported $1.08 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.03 by $0.05. The business had revenue of $1.20 billion during the quarter, compared to the consensus estimate of $1.20 billion. AMETEK had a return on equity of 16.29% and a net margin of 18.77%. The firm’s revenue for the quarter was down 8.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.08 earnings per share. Equities analysts anticipate that AMETEK, Inc. will post 3.9 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 31st. Shareholders of record on Monday, March 15th were issued a $0.20 dividend. This is an increase from AMETEK’s previous quarterly dividend of $0.18. This represents a $0.80 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date was Friday, March 12th. AMETEK’s payout ratio is presently 19.09%.
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.
Featured Article: What is a Stop Order?
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.